'en:assessment of depression severity at the initial evaluation'
(id=8087907 ; fe=en:assessment of depression severity at the initial evaluation ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=8850 creation date=2017-07-21 touchdate=2024-10-09 22:24:24.000)

≈ 237 relations sortantes en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer n1=en:assessment of depression severity at the initial evaluation | n2=en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet n1=en:assessment of depression severity at the initial evaluation | n2=en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter n1=en:assessment of depression severity at the initial evaluation | n2=en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter n1=en:assessment of depression severity at the initial evaluation | n2=en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record n1=en:assessment of depression severity at the initial evaluation | n2=en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed n1=en:assessment of depression severity at the initial evaluation | n2=en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:injection, ziv-aflibercept, 1 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, ziv-aflibercept, 1 mg | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:ldl-c not performed, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:ldl-c not performed, reason not given | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:ldl-c was not performed n1=en:assessment of depression severity at the initial evaluation | n2=en:ldl-c was not performed | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:patient not treated for reading disorder n1=en:assessment of depression severity at the initial evaluation | n2=en:patient not treated for reading disorder | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge n1=en:assessment of depression severity at the initial evaluation | n2=en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:score on the swallowing functional communication measure at discharge was higher than at admission n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the swallowing functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) n1=en:assessment of depression severity at the initial evaluation | n2=en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 30 / 1 -> en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission n1=en:assessment of depression severity at the initial evaluation | n2=en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission | rel=r_associated | relid=0 | w=30 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment) | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:injection, morphine sulfate, 100mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, morphine sulfate, 100mg | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:injection, peginesatide, 0.1 mg (for esrd on dialysis) n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, peginesatide, 0.1 mg (for esrd on dialysis) | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:patient documentation - angina assessed as absent n1=en:assessment of depression severity at the initial evaluation | n2=en:patient documentation - angina assessed as absent | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) n1=en:assessment of depression severity at the initial evaluation | n2=en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:score on the motor speech functional communication measure at discharge was higher than at admission n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the motor speech functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:score on the motor speech functional communication measure at discharge was not higher than at admission, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the motor speech functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer n1=en:assessment of depression severity at the initial evaluation | n2=en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 29 / 0.967 -> en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap n1=en:assessment of depression severity at the initial evaluation | n2=en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | rel=r_associated | relid=0 | w=29 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed n1=en:assessment of depression severity at the initial evaluation | n2=en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:anti-lipid treatment at discharge n1=en:assessment of depression severity at the initial evaluation | n2=en:anti-lipid treatment at discharge | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation) n1=en:assessment of depression severity at the initial evaluation | n2=en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation) | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:complete gene sequence analysis; mlh1 gene n1=en:assessment of depression severity at the initial evaluation | n2=en:complete gene sequence analysis; mlh1 gene | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:documentation of diagnosis of chronic kidney disease n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of diagnosis of chronic kidney disease | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:i intend to report the community-acquired pneumonia (cap) measures group n1=en:assessment of depression severity at the initial evaluation | n2=en:i intend to report the community-acquired pneumonia (cap) measures group | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:injection, zoledronic acid (zometa), 1 mg administered n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, zoledronic acid (zometa), 1 mg administered | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:lipid profile not performed, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:lipid profile not performed, reason not given | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:most recent blood pressure under control n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent blood pressure under control | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:oral aspirin or other antithrombotic therapy prescribed n1=en:assessment of depression severity at the initial evaluation | n2=en:oral aspirin or other antithrombotic therapy prescribed | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:patient had a medical visit in the last 6 months n1=en:assessment of depression severity at the initial evaluation | n2=en:patient had a medical visit in the last 6 months | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:patient not treated for spoken language expression disorder n1=en:assessment of depression severity at the initial evaluation | n2=en:patient not treated for spoken language expression disorder | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:patient treated for spoken language comprehension but not scored on the spoken language comprehension functional communication measure either at admission or at discharge n1=en:assessment of depression severity at the initial evaluation | n2=en:patient treated for spoken language comprehension but not scored on the spoken language comprehension functional communication measure either at admission or at discharge | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase n1=en:assessment of depression severity at the initial evaluation | n2=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches n1=en:assessment of depression severity at the initial evaluation | n2=en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:pregnancy test (urine or serum) was not ordered, reason not specified n1=en:assessment of depression severity at the initial evaluation | n2=en:pregnancy test (urine or serum) was not ordered, reason not specified | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:prescription(s) generated and transmitted via a qualified erx system n1=en:assessment of depression severity at the initial evaluation | n2=en:prescription(s) generated and transmitted via a qualified erx system | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge n1=en:assessment of depression severity at the initial evaluation | n2=en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 28 / 0.933 -> en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea n1=en:assessment of depression severity at the initial evaluation | n2=en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea | rel=r_associated | relid=0 | w=28 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:electronic wrist rotator, otto bock or equal n1=en:assessment of depression severity at the initial evaluation | n2=en:electronic wrist rotator, otto bock or equal | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy n1=en:assessment of depression severity at the initial evaluation | n2=en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain n1=en:assessment of depression severity at the initial evaluation | n2=en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:injection, alemtuzumab, 10 mg administered n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, alemtuzumab, 10 mg administered | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:injection, factor viii, fc fusion protein, (recombinant), per i.u. n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, factor viii, fc fusion protein, (recombinant), per i.u. | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:injection, sulfur hexafluoride lipid microsphere, per ml n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, sulfur hexafluoride lipid microsphere, per ml | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:miscellaneous supply or accessory for use with ventricular assist device n1=en:assessment of depression severity at the initial evaluation | n2=en:miscellaneous supply or accessory for use with ventricular assist device | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:patient receiving antiviral treatment for hepatitis c documented n1=en:assessment of depression severity at the initial evaluation | n2=en:patient receiving antiviral treatment for hepatitis c documented | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine n1=en:assessment of depression severity at the initial evaluation | n2=en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:prednisone, oral, per 5 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:prednisone, oral, per 5 mg | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:score on the attention functional communication measure at discharge was higher than at admission n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the attention functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens n1=en:assessment of depression severity at the initial evaluation | n2=en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device n1=en:assessment of depression severity at the initial evaluation | n2=en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 27 / 0.9 -> en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel n1=en:assessment of depression severity at the initial evaluation | n2=en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel | rel=r_associated | relid=0 | w=27 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:abdominal aortic aneurysm is not infarenal n1=en:assessment of depression severity at the initial evaluation | n2=en:abdominal aortic aneurysm is not infarenal | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen n1=en:assessment of depression severity at the initial evaluation | n2=en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u. n1=en:assessment of depression severity at the initial evaluation | n2=en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u. | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. n1=en:assessment of depression severity at the initial evaluation | n2=en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:fluocinolone acetonide, intravitreal implant n1=en:assessment of depression severity at the initial evaluation | n2=en:fluocinolone acetonide, intravitreal implant | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:follow-up cta, duplex, or mra of the abdomen and pelvis performed n1=en:assessment of depression severity at the initial evaluation | n2=en:follow-up cta, duplex, or mra of the abdomen and pelvis performed | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:i intend to report the hypertension (htn) measures group n1=en:assessment of depression severity at the initial evaluation | n2=en:i intend to report the hypertension (htn) measures group | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit n1=en:assessment of depression severity at the initial evaluation | n2=en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:no anti-lipid treatment at discharge n1=en:assessment of depression severity at the initial evaluation | n2=en:no anti-lipid treatment at discharge | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge n1=en:assessment of depression severity at the initial evaluation | n2=en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents n1=en:assessment of depression severity at the initial evaluation | n2=en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:score on the spoken language expression functional communication measure at discharge was higher than at admission n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the spoken language expression functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 26 / 0.867 -> en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries n1=en:assessment of depression severity at the initial evaluation | n2=en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries | rel=r_associated | relid=0 | w=26 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:assessment n1=en:assessment of depression severity at the initial evaluation | n2=en:assessment | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:hcpcs level ii preferred terms, obsolete n1=en:assessment of depression severity at the initial evaluation | n2=en:hcpcs level ii preferred terms, obsolete | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:injection, human fibrinogen concentrate, 100 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, human fibrinogen concentrate, 100 mg | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:most recent ldl-c not under control, results documented and reviewed n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent ldl-c not under control, results documented and reviewed | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:most recent office visit diastolic blood pressure, 80 - 89 mm hg n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent office visit diastolic blood pressure, 80 - 89 mm hg | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility n1=en:assessment of depression severity at the initial evaluation | n2=en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:patient not treated for memory disorder n1=en:assessment of depression severity at the initial evaluation | n2=en:patient not treated for memory disorder | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge n1=en:assessment of depression severity at the initial evaluation | n2=en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase n1=en:assessment of depression severity at the initial evaluation | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase n1=en:assessment of depression severity at the initial evaluation | n2=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:pneumocystis jiroveci pneumonia prophlaxis prescribed n1=en:assessment of depression severity at the initial evaluation | n2=en:pneumocystis jiroveci pneumonia prophlaxis prescribed | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:score on the writing functional communication measure at discharge was higher than at admission n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the writing functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:suicide risk assessed at the initial evaluation n1=en:assessment of depression severity at the initial evaluation | n2=en:suicide risk assessed at the initial evaluation | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 25 / 0.833 -> en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act n1=en:assessment of depression severity at the initial evaluation | n2=en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | rel=r_associated | relid=0 | w=25 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:antiplatelet medication contraindicated n1=en:assessment of depression severity at the initial evaluation | n2=en:antiplatelet medication contraindicated | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:beta-blocker at discharge n1=en:assessment of depression severity at the initial evaluation | n2=en:beta-blocker at discharge | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap n1=en:assessment of depression severity at the initial evaluation | n2=en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month n1=en:assessment of depression severity at the initial evaluation | n2=en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:counseling for diet and physical activity performed n1=en:assessment of depression severity at the initial evaluation | n2=en:counseling for diet and physical activity performed | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:diabetes screening test not performed, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:diabetes screening test not performed, reason not given | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes n1=en:assessment of depression severity at the initial evaluation | n2=en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:grafix prime, per square centimeter n1=en:assessment of depression severity at the initial evaluation | n2=en:grafix prime, per square centimeter | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:i intend to report the back pain measures group n1=en:assessment of depression severity at the initial evaluation | n2=en:i intend to report the back pain measures group | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) n1=en:assessment of depression severity at the initial evaluation | n2=en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:injection, brentuximab vedotin, 1 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, brentuximab vedotin, 1 mg | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:injection, ferric carboxymaltose, 1 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, ferric carboxymaltose, 1 mg | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:injection, medroxyprogesterone acetate, 50 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, medroxyprogesterone acetate, 50 mg | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:injection, testosterone cypionate, up to 100 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, testosterone cypionate, up to 100 mg | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed n1=en:assessment of depression severity at the initial evaluation | n2=en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:level of activity and symptoms not assessed n1=en:assessment of depression severity at the initial evaluation | n2=en:level of activity and symptoms not assessed | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason n1=en:assessment of depression severity at the initial evaluation | n2=en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:patient documentation - angina assessed as present n1=en:assessment of depression severity at the initial evaluation | n2=en:patient documentation - angina assessed as present | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days n1=en:assessment of depression severity at the initial evaluation | n2=en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:score on the reading functional communication measure at discharge was higher than at admission n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the reading functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act n1=en:assessment of depression severity at the initial evaluation | n2=en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:unlisted procedure, intestine n1=en:assessment of depression severity at the initial evaluation | n2=en:unlisted procedure, intestine | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 24 / 0.8 -> en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) n1=en:assessment of depression severity at the initial evaluation | n2=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | rel=r_associated | relid=0 | w=24 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression n1=en:assessment of depression severity at the initial evaluation | n2=en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:compounded drug, not otherwise classified n1=en:assessment of depression severity at the initial evaluation | n2=en:compounded drug, not otherwise classified | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:genetic testing for canavan disease n1=en:assessment of depression severity at the initial evaluation | n2=en:genetic testing for canavan disease | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes n1=en:assessment of depression severity at the initial evaluation | n2=en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:i intend to report the epilepsy measures group n1=en:assessment of depression severity at the initial evaluation | n2=en:i intend to report the epilepsy measures group | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.) n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.) | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:injection, testosterone enanthate, up to 100 mg administered n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, testosterone enanthate, up to 100 mg administered | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:injection, testosterone enanthate, up to 200 mg administered n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, testosterone enanthate, up to 200 mg administered | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:levonorgestrel 52mg intrauterine system n1=en:assessment of depression severity at the initial evaluation | n2=en:levonorgestrel 52mg intrauterine system | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) n1=en:assessment of depression severity at the initial evaluation | n2=en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:most recent ldl-c under control, results documented and reviewed n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent ldl-c under control, results documented and reviewed | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery n1=en:assessment of depression severity at the initial evaluation | n2=en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:patient not treated for motor speech disorder n1=en:assessment of depression severity at the initial evaluation | n2=en:patient not treated for motor speech disorder | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days n1=en:assessment of depression severity at the initial evaluation | n2=en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 23 / 0.767 -> en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=23 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique n1=en:assessment of depression severity at the initial evaluation | n2=en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:i intend to report the perioperative care measures group n1=en:assessment of depression severity at the initial evaluation | n2=en:i intend to report the perioperative care measures group | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a n1=en:assessment of depression severity at the initial evaluation | n2=en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:netupitant 300 mg and palonosetron 0.5 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:netupitant 300 mg and palonosetron 0.5 mg | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:patch closure used for patient undergoing conventional cea n1=en:assessment of depression severity at the initial evaluation | n2=en:patch closure used for patient undergoing conventional cea | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit n1=en:assessment of depression severity at the initial evaluation | n2=en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) n1=en:assessment of depression severity at the initial evaluation | n2=en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:patient not treated for attention disorder n1=en:assessment of depression severity at the initial evaluation | n2=en:patient not treated for attention disorder | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days n1=en:assessment of depression severity at the initial evaluation | n2=en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:positive airway pressure therapy not prescribed n1=en:assessment of depression severity at the initial evaluation | n2=en:positive airway pressure therapy not prescribed | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 22 / 0.733 -> en:serum creatinine test not performed, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:serum creatinine test not performed, reason not given | rel=r_associated | relid=0 | w=22 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient n1=en:assessment of depression severity at the initial evaluation | n2=en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:assessed level of activity and symptoms n1=en:assessment of depression severity at the initial evaluation | n2=en:assessed level of activity and symptoms | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:counseling for diet and physical activity not performed, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:counseling for diet and physical activity not performed, reason not given | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) n1=en:assessment of depression severity at the initial evaluation | n2=en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:genetic testing for gaucher disease n1=en:assessment of depression severity at the initial evaluation | n2=en:genetic testing for gaucher disease | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:injection, ocriplasmin, 0.125 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, ocriplasmin, 0.125 mg | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:injection, sculptra, 0.1 ml n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, sculptra, 0.1 ml | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:injection, taliglucerase alfa, 10 units n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, taliglucerase alfa, 10 units | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) n1=en:assessment of depression severity at the initial evaluation | n2=en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:no documentation of disease type, anatomic location, and activity, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:no documentation of disease type, anatomic location, and activity, reason not given | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:patients with a positive hepatitis c antibody test n1=en:assessment of depression severity at the initial evaluation | n2=en:patients with a positive hepatitis c antibody test | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:pregnancy test (urine or serum) not ordered for reasons documented by clinician n1=en:assessment of depression severity at the initial evaluation | n2=en:pregnancy test (urine or serum) not ordered for reasons documented by clinician | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen n1=en:assessment of depression severity at the initial evaluation | n2=en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen n1=en:assessment of depression severity at the initial evaluation | n2=en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:prostate cancer antigen 3 (pca3) testing n1=en:assessment of depression severity at the initial evaluation | n2=en:prostate cancer antigen 3 (pca3) testing | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:rehabilitation services were not ordered, reason not otherwise specified n1=en:assessment of depression severity at the initial evaluation | n2=en:rehabilitation services were not ordered, reason not otherwise specified | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:severity of angina assessed according to level of activity n1=en:assessment of depression severity at the initial evaluation | n2=en:severity of angina assessed according to level of activity | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:suicide risk not assessed at the initial evaluation, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:suicide risk not assessed at the initial evaluation, reason not given | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals n1=en:assessment of depression severity at the initial evaluation | n2=en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) n1=en:assessment of depression severity at the initial evaluation | n2=en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:urine protein test was not performed, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:urine protein test was not performed, reason not given | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:vacuum drainage bottle and tubing for use with implanted catheter n1=en:assessment of depression severity at the initial evaluation | n2=en:vacuum drainage bottle and tubing for use with implanted catheter | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 21 / 0.7 -> en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) n1=en:assessment of depression severity at the initial evaluation | n2=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) | rel=r_associated | relid=0 | w=21 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation) n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation) | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively n1=en:assessment of depression severity at the initial evaluation | n2=en:documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:fetal aneuploidy (trisomy 21, 18, and 13) dna sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy n1=en:assessment of depression severity at the initial evaluation | n2=en:fetal aneuploidy (trisomy 21, 18, and 13) dna sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:gene expression profiling panel for use in the management of breast cancer treatment n1=en:assessment of depression severity at the initial evaluation | n2=en:gene expression profiling panel for use in the management of breast cancer treatment | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:i intend to report the ischemic vascular disease (ivd) measures group n1=en:assessment of depression severity at the initial evaluation | n2=en:i intend to report the ischemic vascular disease (ivd) measures group | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) n1=en:assessment of depression severity at the initial evaluation | n2=en:immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:implanted pleural catheter, each n1=en:assessment of depression severity at the initial evaluation | n2=en:implanted pleural catheter, each | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:influenza a (h1n1) vaccine, any route of administration n1=en:assessment of depression severity at the initial evaluation | n2=en:influenza a (h1n1) vaccine, any route of administration | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:injection, belinostat, 10 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, belinostat, 10 mg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:injection, certolizumab pegol, 1 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, certolizumab pegol, 1 mg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:injection, interferon beta-1a, 11 mcg for subcutaneous use n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, interferon beta-1a, 11 mcg for subcutaneous use | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:injection, medroxyprogesterone acetate / estradiol cypionate, 5mg / 25mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, medroxyprogesterone acetate / estradiol cypionate, 5mg / 25mg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:injection, pertuzumab, 10 mg n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, pertuzumab, 10 mg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:injection, tbo-filgrastim, 5 micrograms n1=en:assessment of depression severity at the initial evaluation | n2=en:injection, tbo-filgrastim, 5 micrograms | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:intraoperative radiation therapy (single administration) n1=en:assessment of depression severity at the initial evaluation | n2=en:intraoperative radiation therapy (single administration) | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:ldl value >= 100 n1=en:assessment of depression severity at the initial evaluation | n2=en:ldl value >= 100 | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:ldl-c result not present or not within 12 months prior n1=en:assessment of depression severity at the initial evaluation | n2=en:ldl-c result not present or not within 12 months prior | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) n1=en:assessment of depression severity at the initial evaluation | n2=en:lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:make a dead set at n1=en:assessment of depression severity at the initial evaluation | n2=en:make a dead set at | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:mandibular orthopedic repositioning device, each n1=en:assessment of depression severity at the initial evaluation | n2=en:mandibular orthopedic repositioning device, each | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:most current ldl-c <100mg/dl n1=en:assessment of depression severity at the initial evaluation | n2=en:most current ldl-c <100mg/dl | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:most recent diastolic blood pressure >= 90 mm hg n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent diastolic blood pressure >= 90 mm hg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:most recent office visit diastolic blood pressure >=90 mm hg n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent office visit diastolic blood pressure >=90 mm hg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:most recent office visit diastolic blood pressure, <80 mm hg n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent office visit diastolic blood pressure, <80 mm hg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:most recent office visit systolic blood pressure <130 mm hg n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent office visit systolic blood pressure <130 mm hg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:most recent office visit systolic blood pressure >=140 mm hg n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent office visit systolic blood pressure >=140 mm hg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:most recent office visit systolic blood pressure, 130 to 139 mm hg n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent office visit systolic blood pressure, 130 to 139 mm hg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:most recent systolic blood pressure < 130 mm hg n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent systolic blood pressure < 130 mm hg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:most recent systolic blood pressure >= 140 mm hg n1=en:assessment of depression severity at the initial evaluation | n2=en:most recent systolic blood pressure >= 140 mm hg | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:negative pressure ventilator; portable or stationary n1=en:assessment of depression severity at the initial evaluation | n2=en:negative pressure ventilator; portable or stationary | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score n1=en:assessment of depression severity at the initial evaluation | n2=en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:oncology (hepatic), mrna expression levels of 161 genes, utilizing fresh hepatocellular carcinoma tumor tissue, with alpha-fetoprotein level, algorithm reported as a risk classifier n1=en:assessment of depression severity at the initial evaluation | n2=en:oncology (hepatic), mrna expression levels of 161 genes, utilizing fresh hepatocellular carcinoma tumor tissue, with alpha-fetoprotein level, algorithm reported as a risk classifier | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:other symptomatic patient with ipsilateral carotid territory tia or stroke > 120 days prior to cea, or contralateral carotid territory tia or stroke or vertebrobasilar tia or stroke n1=en:assessment of depression severity at the initial evaluation | n2=en:other symptomatic patient with ipsilateral carotid territory tia or stroke > 120 days prior to cea, or contralateral carotid territory tia or stroke or vertebrobasilar tia or stroke | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:patch closure not used for patient undergoing conventional cea, reason not specified n1=en:assessment of depression severity at the initial evaluation | n2=en:patch closure not used for patient undergoing conventional cea, reason not specified | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:patient did not achieve flat retinas six months post surgery n1=en:assessment of depression severity at the initial evaluation | n2=en:patient did not achieve flat retinas six months post surgery | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:patient did not have a medical visit in the last 6 months n1=en:assessment of depression severity at the initial evaluation | n2=en:patient did not have a medical visit in the last 6 months | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:patient did not have the retina attached after 6 months following only one surgery n1=en:assessment of depression severity at the initial evaluation | n2=en:patient did not have the retina attached after 6 months following only one surgery | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:patient documentation - most recent ldl-c < 100 mg/dl n1=en:assessment of depression severity at the initial evaluation | n2=en:patient documentation - most recent ldl-c < 100 mg/dl | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit n1=en:assessment of depression severity at the initial evaluation | n2=en:patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:patient not receiving a first course of anti-tnf therapy n1=en:assessment of depression severity at the initial evaluation | n2=en:patient not receiving a first course of anti-tnf therapy | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:patient treated for attention but not scored on the attention functional communication measure either at admission or at discharge n1=en:assessment of depression severity at the initial evaluation | n2=en:patient treated for attention but not scored on the attention functional communication measure either at admission or at discharge | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:patient treated for motor speech but not scored on the motor speech comprehension functional communication measure either at admission or at discharge n1=en:assessment of depression severity at the initial evaluation | n2=en:patient treated for motor speech but not scored on the motor speech comprehension functional communication measure either at admission or at discharge | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase n1=en:assessment of depression severity at the initial evaluation | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen n1=en:assessment of depression severity at the initial evaluation | n2=en:perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:pregnancy test (urine or serum) ordered n1=en:assessment of depression severity at the initial evaluation | n2=en:pregnancy test (urine or serum) ordered | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation n1=en:assessment of depression severity at the initial evaluation | n2=en:referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:score on the attention functional communication measure at discharge was not higher than at admission, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the attention functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:score on the memory functional communication measure at discharge was higher than at admission n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the memory functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:score on the spoken language comprehension functional communication measure at discharge was not higher than at admission, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:score on the spoken language comprehension functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:serum creatinine test result documented and reviewed n1=en:assessment of depression severity at the initial evaluation | n2=en:serum creatinine test result documented and reviewed | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation) n1=en:assessment of depression severity at the initial evaluation | n2=en:sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation) | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:skin substitute, endoform dermal template, per square centimeter n1=en:assessment of depression severity at the initial evaluation | n2=en:skin substitute, endoform dermal template, per square centimeter | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:smoking status and exposure to second hand smoke in the home not assessed, reason not given n1=en:assessment of depression severity at the initial evaluation | n2=en:smoking status and exposure to second hand smoke in the home not assessed, reason not given | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:spirometry test results demonstrate fev1 >= 60% predicted or patient does not have copd symptoms n1=en:assessment of depression severity at the initial evaluation | n2=en:spirometry test results demonstrate fev1 >= 60% predicted or patient does not have copd symptoms | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, >60 specimens n1=en:assessment of depression severity at the initial evaluation | n2=en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, >60 specimens | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:to be not much to look at n1=en:assessment of depression severity at the initial evaluation | n2=en:to be not much to look at | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel n1=en:assessment of depression severity at the initial evaluation | n2=en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel | rel=r_associated | relid=0 | w=20 en:assessment of depression severity at the initial evaluation -- r_associated #0: 20 / 0.667 -> en:type, anatomic location, and activity all documented n1=en:assessment of depression severity at the initial evaluation | n2=en:type, anatomic location, and activity all documented | rel=r_associated | relid=0 | w=20

≈ 377 relations entrantes en:injection, taliglucerase alfa, 10 units --- r_associated #0: 43 --> en:assessment of depression severity at the initial evaluation n1=en:injection, taliglucerase alfa, 10 units | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=43 en:score on the motor speech functional communication measure at discharge was higher than at admission --- r_associated #0: 43 --> en:assessment of depression severity at the initial evaluation n1=en:score on the motor speech functional communication measure at discharge was higher than at admission | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=43 en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet --- r_associated #0: 42 --> en:assessment of depression severity at the initial evaluation n1=en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=42 en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 42 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=42 en:complete gene sequence analysis; mlh1 gene --- r_associated #0: 41 --> en:assessment of depression severity at the initial evaluation n1=en:complete gene sequence analysis; mlh1 gene | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=41 en:injection, alemtuzumab, 10 mg administered --- r_associated #0: 41 --> en:assessment of depression severity at the initial evaluation n1=en:injection, alemtuzumab, 10 mg administered | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=41 en:injection, medroxyprogesterone acetate / estradiol cypionate, 5mg / 25mg --- r_associated #0: 41 --> en:assessment of depression severity at the initial evaluation n1=en:injection, medroxyprogesterone acetate / estradiol cypionate, 5mg / 25mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=41 en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given --- r_associated #0: 41 --> en:assessment of depression severity at the initial evaluation n1=en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=41 en:positive airway pressure therapy not prescribed --- r_associated #0: 41 --> en:assessment of depression severity at the initial evaluation n1=en:positive airway pressure therapy not prescribed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=41 en:counseling for diet and physical activity performed --- r_associated #0: 40 --> en:assessment of depression severity at the initial evaluation n1=en:counseling for diet and physical activity performed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=40 en:level of activity and symptoms not assessed --- r_associated #0: 40 --> en:assessment of depression severity at the initial evaluation n1=en:level of activity and symptoms not assessed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=40 en:patient treated for attention but not scored on the attention functional communication measure either at admission or at discharge --- r_associated #0: 40 --> en:assessment of depression severity at the initial evaluation n1=en:patient treated for attention but not scored on the attention functional communication measure either at admission or at discharge | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=40 en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days --- r_associated #0: 40 --> en:assessment of depression severity at the initial evaluation n1=en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=40 en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap --- r_associated #0: 40 --> en:assessment of depression severity at the initial evaluation n1=en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=40 en:smoking status and exposure to second hand smoke in the home not assessed, reason not given --- r_associated #0: 40 --> en:assessment of depression severity at the initial evaluation n1=en:smoking status and exposure to second hand smoke in the home not assessed, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=40 en:injection, testosterone enanthate, up to 100 mg administered --- r_associated #0: 39 --> en:assessment of depression severity at the initial evaluation n1=en:injection, testosterone enanthate, up to 100 mg administered | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=39 en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit --- r_associated #0: 39 --> en:assessment of depression severity at the initial evaluation n1=en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=39 en:ldl-c not performed, reason not given --- r_associated #0: 38 --> en:assessment of depression severity at the initial evaluation n1=en:ldl-c not performed, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=38 en:most recent office visit systolic blood pressure >=140 mm hg --- r_associated #0: 38 --> en:assessment of depression severity at the initial evaluation n1=en:most recent office visit systolic blood pressure >=140 mm hg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=38 en:score on the reading functional communication measure at discharge was higher than at admission --- r_associated #0: 38 --> en:assessment of depression severity at the initial evaluation n1=en:score on the reading functional communication measure at discharge was higher than at admission | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=38 en:documentation of diagnosis of chronic kidney disease --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of diagnosis of chronic kidney disease | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u. --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u. | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:genetic testing for gaucher disease --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:genetic testing for gaucher disease | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.) --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:injection, human fibrinogen concentrate, 100 mg --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:injection, human fibrinogen concentrate, 100 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:injection, morphine sulfate, 100mg --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:injection, morphine sulfate, 100mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:injection, ziv-aflibercept, 1 mg --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:injection, ziv-aflibercept, 1 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:miscellaneous supply or accessory for use with ventricular assist device --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:miscellaneous supply or accessory for use with ventricular assist device | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:pregnancy test (urine or serum) was not ordered, reason not specified --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:pregnancy test (urine or serum) was not ordered, reason not specified | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 36 --> en:assessment of depression severity at the initial evaluation n1=en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=36 en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:follow-up cta, duplex, or mra of the abdomen and pelvis performed --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:follow-up cta, duplex, or mra of the abdomen and pelvis performed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:gene expression profiling panel for use in the management of breast cancer treatment --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:gene expression profiling panel for use in the management of breast cancer treatment | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:injection, pertuzumab, 10 mg --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:injection, pertuzumab, 10 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:injection, zoledronic acid (zometa), 1 mg administered --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:injection, zoledronic acid (zometa), 1 mg administered | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:ldl-c result not present or not within 12 months prior --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:ldl-c result not present or not within 12 months prior | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:levonorgestrel 52mg intrauterine system --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:levonorgestrel 52mg intrauterine system | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:most recent office visit systolic blood pressure, 130 to 139 mm hg --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:most recent office visit systolic blood pressure, 130 to 139 mm hg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:patient documentation - angina assessed as absent --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:patient documentation - angina assessed as absent | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:prednisone, oral, per 5 mg --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:prednisone, oral, per 5 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:pregnancy test (urine or serum) not ordered for reasons documented by clinician --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:pregnancy test (urine or serum) not ordered for reasons documented by clinician | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:prescription(s) generated and transmitted via a qualified erx system --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:prescription(s) generated and transmitted via a qualified erx system | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation) --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:suicide risk assessed at the initial evaluation --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:suicide risk assessed at the initial evaluation | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) --- r_associated #0: 35 --> en:assessment of depression severity at the initial evaluation n1=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35 en:diabetes screening test not performed, reason not given --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:diabetes screening test not performed, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation) --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:fluocinolone acetonide, intravitreal implant --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:fluocinolone acetonide, intravitreal implant | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:hcpcs level ii preferred terms, obsolete --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:hcpcs level ii preferred terms, obsolete | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:i intend to report the epilepsy measures group --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:i intend to report the epilepsy measures group | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:i intend to report the ischemic vascular disease (ivd) measures group --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:i intend to report the ischemic vascular disease (ivd) measures group | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:injection, ferric carboxymaltose, 1 mg --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:injection, ferric carboxymaltose, 1 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:injection, ocriplasmin, 0.125 mg --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:injection, ocriplasmin, 0.125 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:injection, testosterone enanthate, up to 200 mg administered --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:injection, testosterone enanthate, up to 200 mg administered | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:mandibular orthopedic repositioning device, each --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:mandibular orthopedic repositioning device, each | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:most recent blood pressure under control --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:most recent blood pressure under control | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:most recent office visit diastolic blood pressure, 80 - 89 mm hg --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:most recent office visit diastolic blood pressure, 80 - 89 mm hg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:netupitant 300 mg and palonosetron 0.5 mg --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:netupitant 300 mg and palonosetron 0.5 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:no anti-lipid treatment at discharge --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:no anti-lipid treatment at discharge | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:patient did not achieve flat retinas six months post surgery --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:patient did not achieve flat retinas six months post surgery | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:patient documentation - angina assessed as present --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:patient documentation - angina assessed as present | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:patient documentation - most recent ldl-c < 100 mg/dl --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:patient documentation - most recent ldl-c < 100 mg/dl | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:patient not receiving a first course of anti-tnf therapy --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:patient not receiving a first course of anti-tnf therapy | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:rehabilitation services were not ordered, reason not otherwise specified --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:rehabilitation services were not ordered, reason not otherwise specified | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:score on the attention functional communication measure at discharge was higher than at admission --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:score on the attention functional communication measure at discharge was higher than at admission | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:score on the motor speech functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:score on the motor speech functional communication measure at discharge was not higher than at admission, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:score on the spoken language comprehension functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:score on the spoken language comprehension functional communication measure at discharge was not higher than at admission, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:score on the spoken language expression functional communication measure at discharge was higher than at admission --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:score on the spoken language expression functional communication measure at discharge was higher than at admission | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:skin substitute, endoform dermal template, per square centimeter --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:skin substitute, endoform dermal template, per square centimeter | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:suicide risk not assessed at the initial evaluation, reason not given --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:suicide risk not assessed at the initial evaluation, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:urine protein test was not performed, reason not given --- r_associated #0: 34 --> en:assessment of depression severity at the initial evaluation n1=en:urine protein test was not performed, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=34 en:beta-blocker at discharge --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:beta-blocker at discharge | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment) --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:fetal aneuploidy (trisomy 21, 18, and 13) dna sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:fetal aneuploidy (trisomy 21, 18, and 13) dna sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:genetic testing for canavan disease --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:genetic testing for canavan disease | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:i intend to report the back pain measures group --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:i intend to report the back pain measures group | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:i intend to report the perioperative care measures group --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:i intend to report the perioperative care measures group | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:injection, interferon beta-1a, 11 mcg for subcutaneous use --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:injection, interferon beta-1a, 11 mcg for subcutaneous use | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:injection, medroxyprogesterone acetate, 50 mg --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:injection, medroxyprogesterone acetate, 50 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:most recent ldl-c not under control, results documented and reviewed --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:most recent ldl-c not under control, results documented and reviewed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:most recent office visit systolic blood pressure <130 mm hg --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:most recent office visit systolic blood pressure <130 mm hg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:no documentation of disease type, anatomic location, and activity, reason not given --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:no documentation of disease type, anatomic location, and activity, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given --- r_associated #0: 32 --> en:assessment of depression severity at the initial evaluation n1=en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=32 en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:anti-lipid treatment at discharge --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:anti-lipid treatment at discharge | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation) --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:electronic wrist rotator, otto bock or equal --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:electronic wrist rotator, otto bock or equal | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:injection, peginesatide, 0.1 mg (for esrd on dialysis) --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:injection, peginesatide, 0.1 mg (for esrd on dialysis) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:most recent systolic blood pressure < 130 mm hg --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:most recent systolic blood pressure < 130 mm hg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:negative pressure ventilator; portable or stationary --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:negative pressure ventilator; portable or stationary | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:oral aspirin or other antithrombotic therapy prescribed --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:oral aspirin or other antithrombotic therapy prescribed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:patient had a medical visit in the last 6 months --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:patient had a medical visit in the last 6 months | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:patient not treated for memory disorder --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:patient not treated for memory disorder | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:patient not treated for reading disorder --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:patient not treated for reading disorder | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:score on the memory functional communication measure at discharge was higher than at admission --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:score on the memory functional communication measure at discharge was higher than at admission | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:score on the swallowing functional communication measure at discharge was higher than at admission --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:score on the swallowing functional communication measure at discharge was higher than at admission | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals --- r_associated #0: 31 --> en:assessment of depression severity at the initial evaluation n1=en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=31 en:abdominal aortic aneurysm is not infarenal --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:abdominal aortic aneurysm is not infarenal | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:assessed level of activity and symptoms --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:assessed level of activity and symptoms | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:i intend to report the hypertension (htn) measures group --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:i intend to report the hypertension (htn) measures group | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:injection, certolizumab pegol, 1 mg --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:injection, certolizumab pegol, 1 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:ldl-c was not performed --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:ldl-c was not performed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:most current ldl-c <100mg/dl --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:most current ldl-c <100mg/dl | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:oncology (hepatic), mrna expression levels of 161 genes, utilizing fresh hepatocellular carcinoma tumor tissue, with alpha-fetoprotein level, algorithm reported as a risk classifier --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:oncology (hepatic), mrna expression levels of 161 genes, utilizing fresh hepatocellular carcinoma tumor tissue, with alpha-fetoprotein level, algorithm reported as a risk classifier | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:patient treated for spoken language comprehension but not scored on the spoken language comprehension functional communication measure either at admission or at discharge --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:patient treated for spoken language comprehension but not scored on the spoken language comprehension functional communication measure either at admission or at discharge | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:patients with a positive hepatitis c antibody test --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:patients with a positive hepatitis c antibody test | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:score on the attention functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:score on the attention functional communication measure at discharge was not higher than at admission, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:spirometry test results demonstrate fev1 >= 60% predicted or patient does not have copd symptoms --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:spirometry test results demonstrate fev1 >= 60% predicted or patient does not have copd symptoms | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, >60 specimens --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, >60 specimens | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:unlisted procedure, intestine --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:unlisted procedure, intestine | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:vacuum drainage bottle and tubing for use with implanted catheter --- r_associated #0: 30 --> en:assessment of depression severity at the initial evaluation n1=en:vacuum drainage bottle and tubing for use with implanted catheter | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=30 en:counseling for diet and physical activity not performed, reason not given --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:counseling for diet and physical activity not performed, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:injection, brentuximab vedotin, 1 mg --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:injection, brentuximab vedotin, 1 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:injection, factor viii, fc fusion protein, (recombinant), per i.u. --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:injection, factor viii, fc fusion protein, (recombinant), per i.u. | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:injection, sulfur hexafluoride lipid microsphere, per ml --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:injection, sulfur hexafluoride lipid microsphere, per ml | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:injection, testosterone cypionate, up to 100 mg --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:injection, testosterone cypionate, up to 100 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:intraoperative radiation therapy (single administration) --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:intraoperative radiation therapy (single administration) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:make a dead set at --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:make a dead set at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:most recent ldl-c under control, results documented and reviewed --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:most recent ldl-c under control, results documented and reviewed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:patient did not have the retina attached after 6 months following only one surgery --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:patient did not have the retina attached after 6 months following only one surgery | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:patient receiving antiviral treatment for hepatitis c documented --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:patient receiving antiviral treatment for hepatitis c documented | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:patient treated for motor speech but not scored on the motor speech comprehension functional communication measure either at admission or at discharge --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:patient treated for motor speech but not scored on the motor speech comprehension functional communication measure either at admission or at discharge | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:score on the writing functional communication measure at discharge was higher than at admission --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:score on the writing functional communication measure at discharge was higher than at admission | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:serum creatinine test not performed, reason not given --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:serum creatinine test not performed, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission --- r_associated #0: 29 --> en:assessment of depression severity at the initial evaluation n1=en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=29 en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:grafix prime, per square centimeter --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:grafix prime, per square centimeter | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:i intend to report the community-acquired pneumonia (cap) measures group --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:i intend to report the community-acquired pneumonia (cap) measures group | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:implanted pleural catheter, each --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:implanted pleural catheter, each | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:injection, sculptra, 0.1 ml --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:injection, sculptra, 0.1 ml | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:lipid profile not performed, reason not given --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:lipid profile not performed, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:most recent diastolic blood pressure >= 90 mm hg --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:most recent diastolic blood pressure >= 90 mm hg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:most recent office visit diastolic blood pressure >=90 mm hg --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:most recent office visit diastolic blood pressure >=90 mm hg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:patch closure not used for patient undergoing conventional cea, reason not specified --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:patch closure not used for patient undergoing conventional cea, reason not specified | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:patient not treated for attention disorder --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:patient not treated for attention disorder | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:patient not treated for spoken language expression disorder --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:patient not treated for spoken language expression disorder | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:pneumocystis jiroveci pneumonia prophlaxis prescribed --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:pneumocystis jiroveci pneumonia prophlaxis prescribed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:prostate cancer antigen 3 (pca3) testing --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:prostate cancer antigen 3 (pca3) testing | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:to be not much to look at --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:to be not much to look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given --- r_associated #0: 28 --> en:assessment of depression severity at the initial evaluation n1=en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=28 en:antiplatelet medication contraindicated --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:antiplatelet medication contraindicated | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:compounded drug, not otherwise classified --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:compounded drug, not otherwise classified | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:injection, belinostat, 10 mg --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:injection, belinostat, 10 mg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:injection, tbo-filgrastim, 5 micrograms --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:injection, tbo-filgrastim, 5 micrograms | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:most recent systolic blood pressure >= 140 mm hg --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:most recent systolic blood pressure >= 140 mm hg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:patch closure used for patient undergoing conventional cea --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:patch closure used for patient undergoing conventional cea | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:patient not treated for motor speech disorder --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:patient not treated for motor speech disorder | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:pregnancy test (urine or serum) ordered --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:pregnancy test (urine or serum) ordered | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:serum creatinine test result documented and reviewed --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:serum creatinine test result documented and reviewed | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:severity of angina assessed according to level of activity --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:severity of angina assessed according to level of activity | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act --- r_associated #0: 27 --> en:assessment of depression severity at the initial evaluation n1=en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=27 en:influenza a (h1n1) vaccine, any route of administration --- r_associated #0: 26 --> en:assessment of depression severity at the initial evaluation n1=en:influenza a (h1n1) vaccine, any route of administration | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=26 en:ldl value >= 100 --- r_associated #0: 26 --> en:assessment of depression severity at the initial evaluation n1=en:ldl value >= 100 | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=26 en:most recent office visit diastolic blood pressure, <80 mm hg --- r_associated #0: 26 --> en:assessment of depression severity at the initial evaluation n1=en:most recent office visit diastolic blood pressure, <80 mm hg | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=26 en:other symptomatic patient with ipsilateral carotid territory tia or stroke > 120 days prior to cea, or contralateral carotid territory tia or stroke or vertebrobasilar tia or stroke --- r_associated #0: 26 --> en:assessment of depression severity at the initial evaluation n1=en:other symptomatic patient with ipsilateral carotid territory tia or stroke > 120 days prior to cea, or contralateral carotid territory tia or stroke or vertebrobasilar tia or stroke | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=26 en:patient did not have a medical visit in the last 6 months --- r_associated #0: 26 --> en:assessment of depression severity at the initial evaluation n1=en:patient did not have a medical visit in the last 6 months | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=26 en:type, anatomic location, and activity all documented --- r_associated #0: 26 --> en:assessment of depression severity at the initial evaluation n1=en:type, anatomic location, and activity all documented | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=26 en:report at --- r_associated #0: 15 --> en:assessment of depression severity at the initial evaluation n1=en:report at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=15 en:to become alarmed at --- r_associated #0: 15 --> en:assessment of depression severity at the initial evaluation n1=en:to become alarmed at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=15 en:to take offense at --- r_associated #0: 15 --> en:assessment of depression severity at the initial evaluation n1=en:to take offense at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=15 en:advantage that's not to be sneezed at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:advantage that's not to be sneezed at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:aiming at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:aiming at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:apt at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:apt at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:be sneezed at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:be sneezed at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:been aimed at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:been aimed at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:end at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:end at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:enrol at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:enrol at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:get back at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:get back at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:get somebody a job at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:get somebody a job at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:get yelled at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:get yelled at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:guess at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:guess at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:have a crack at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:have a crack at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:have a dig at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:have a dig at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:have a pop at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:have a pop at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:have at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:have at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:have its source at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:have its source at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:hitting out at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:hitting out at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:it's not to be sneezed at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:it's not to be sneezed at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:it's not to be sniffed at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:it's not to be sniffed at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:jeer at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:jeer at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:look hard at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:look hard at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:make a rush at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:make a rush at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:make mouths at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:make mouths at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:point the finger at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:point the finger at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:poke fun at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:poke fun at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:putting up at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:putting up at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:rush at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:rush at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:slog away at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:slog away at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:snap away at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:snap away at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:stand at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:stand at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:stare at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:stare at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:stick at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:stick at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:surprised at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:surprised at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:take a crack at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:take a crack at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:take a good look at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:take a good look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:take a grander at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:take a grander at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:taken a good look at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:taken a good look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:throw oneself at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:throw oneself at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:throw stones at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:throw stones at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:tilt at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:tilt at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to be aimed at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to be aimed at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to be at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to be at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to be bad at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to be bad at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to be indignant at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to be indignant at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to be surprised at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to be surprised at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to chuck eggs at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to chuck eggs at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to claw at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to claw at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to connive at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to connive at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to draw up at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to draw up at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to eat at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to eat at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to eat away at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to eat away at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to enquire at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to enquire at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to enrol at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to enrol at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to enrol sb at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to enrol sb at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to excel at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to excel at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to fart about at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to fart about at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to gawp at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to gawp at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to gaze at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to gaze at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to get at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to get at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to get one's hair done at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to get one's hair done at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to gibe at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to gibe at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to gnaw at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to gnaw at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to go all at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to go all at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to go hard at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to go hard at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to guess at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to guess at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to have a good look at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to have a good look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to hint at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to hint at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to jest at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to jest at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to jump at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to jump at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to look askance at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to look askance at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to look at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to make a dead set at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to make a dead set at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to make a rush at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to make a rush at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to make eyes at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to make eyes at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to marvel at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to marvel at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to mock at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to mock at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to peck at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to peck at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to pick at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to pick at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to play at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to play at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to poke at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to poke at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to pounce at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to pounce at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to put in at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to put in at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to quote gold at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to quote gold at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to report at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to report at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to request the pleasure of your company at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to request the pleasure of your company at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to rush at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to rush at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to shine at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to shine at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to shoot at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to shoot at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to shop at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to shop at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to slog away at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to slog away at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to smile at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to smile at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to snap at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to snap at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to snap away at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to snap away at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to sniff at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to sniff at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to stick two fingers up at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to stick two fingers up at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to stop off at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to stop off at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to take a good look at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to take a good look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to take a stab at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to take a stab at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to took a good look at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to took a good look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to try one's hand at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to try one's hand at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to whistle at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to whistle at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:to work at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:to work at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:yell at --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=en:yell at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 n'avoir l'air de rien --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=n'avoir l'air de rien | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 ne pas payer de mine --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=ne pas payer de mine | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 s'alarmer de --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=s'alarmer de | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 s'offusquer de --- r_associated #0: 10 --> en:assessment of depression severity at the initial evaluation n1=s'offusquer de | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=10 en:be good at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:be good at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:be laughed at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:be laughed at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:chafe at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:chafe at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:chaffing at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:chaffing at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:connive at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:connive at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:drive at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:drive at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:have a good look at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:have a good look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:hint at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:hint at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:on arrival at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:on arrival at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:pinch at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:pinch at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:request the pleasure of your company at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:request the pleasure of your company at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:take a look at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:take a look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:tip the scales at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:tip the scales at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to chip at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to chip at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to have a glance at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to have a glance at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to have its source at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to have its source at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to lap at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to lap at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to not much to look at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to not much to look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to not to be sniffed at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to not to be sniffed at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to pluck at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to pluck at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to poke fun at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to poke fun at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to pull at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to pull at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to stay at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to stay at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to stop at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to stop at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to take aim at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to take aim at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to throw eggs at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to throw eggs at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to turn your nose up at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:to turn your nose up at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:took a good look at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:took a good look at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:turn your nose up at --- r_associated #0: 5 --> en:assessment of depression severity at the initial evaluation n1=en:turn your nose up at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=5 en:to take offence at --- r_associated #0: -5 --> en:assessment of depression severity at the initial evaluation n1=en:to take offence at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=-5 % at --- r_associated #0: -31 --> en:assessment of depression severity at the initial evaluation n1=% at | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=-31